In contrast, chronic administration of pharmacological or low doses of rhGH has been shown to negatively affect glucose metabolism in GH-deficient children and adults [1, 20, 21], abdominally obese subjects [22–23], and HIV-infected patients with wasting [24] or lipodystrophy [25–26]. Here, GH1 is linked to lipodystrophy.